Skip to main content
. 2021 Jan 6;23(2):246–256. doi: 10.1016/j.neo.2020.12.008

Fig. 3.

Fig 3

Several areas along the surgical continuum of pancreatic cancer screening, neoadjuvant/adjuvant treatment, outcomes, and surveillance lend itself to involvement of the microbiome. Evidence exists for the involvement of the microbiome in these critical areas that have the potential to impact survival for patients with PDAC.